跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,844 条关于
“Spinocerebellar Ataxia Type 27B”
全部
29,844
临床试验
23,386
药物
901
机构
59
资讯
5,498
去年
Solaxa Advances SLX-100 to Phase 3 Trial for Rare Spinocerebellar Ataxia Type 27B
去年
L-Arginine Shows Promise but Falls Short of Statistical Significance in Spinocerebellar Ataxia Type 6 Trial
去年
CIRM Awards $5.69M Grant to Advance Novel Gene Therapy for Spinocerebellar Ataxia Type 3
去年
Biohaven Withdraws EU Application for Spinocerebellar Ataxia Drug Dazluma
去年
FDA Grants Priority Review to Troriluzole for Spinocerebellar Ataxia Treatment
去年
Biohaven Withdraws EU Application for Troriluzole in Spinocerebellar Ataxia, RBC Remains Optimistic
10个月前
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) for Spinocerebellar Ataxia
2个月前
REPROCELL Submits Application for Stem Cell Therapy Stemchymal in Japan for Spinocerebellar Ataxia SCA3 and SCA6
去年
Biohaven's Troriluzole Shows Promise in Slowing Spinocerebellar Ataxia Progression
去年
Biohaven Prepares for Potential First-in-Class Spinocerebellar Ataxia Drug Launch as FDA Decision Looms
第 1 页，共 550 页
上一页
下一页
